// App-Quantinova.ai

: Late Breaking Abstract - Analysis of the InforMing the PAthway of COPD Treatment (IMPACT) study in the subgroup of patients taking triple therapy at screening

Researchers

Presenter

  • Dave Singh

Principal Investigators

  • Gerard Criner

  • Nicola C. Day

  • Mark Dransfield

  • David M.G. Halpin

  • Meilan K. Han

  • C. Elaine Jones

  • Sally Kilbride

  • Peter Lange

  • David A Lipson

  • David A. Lomas

  • Steve Pascoe

  • Maggie Tabberer

  • Robert Wise

  • Fernando J. Martinez

Medical Centers

  • ARUK Centre for Epidemiology, CfMR, Institute of Inflammation and Repair, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom

  • Lewis Katz School of Medicine at Temple University, Philadelpha , United States of America

  • GSK, Stockley Park West, Uxbridge, Middlesex, United Kingdom,

  • Division of Pulmonary, Allergy, and Critical Care Medicine, Lung Health Center, University of Alabama at Birmingham, Birmingham, AL, United States,

  • Department of Gastroenterology, Royal Devon and Exeter Hospital, Exeter, United Kingdom

  • GlaxoSmithKline, Research Triangle Park, NC, United States.

  • University of Copenhagen, Copenhagen E, Denmark

  • GlaxoSmithKline/Perelman School of Medicine, University of Pennsylvania, Collegeville/Philadelphia, PA, United States of America

  • UCL Respiratory, University College London, London, United Kingdom

  • GlaxoSmithKline plc, Collegeville, United States of America

  • Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, United States of America

  • NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, United States of America

Locations

  • United Kingdom

  • United States

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • fluticasone furoate/umeclidinium/vilanterol

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved